{
    "eid": "2-s2.0-84995519493",
    "title": "Late acute graft-versus-host disease: A prospective analysis of clinical outcomes and circulating angiogenic factors",
    "cover-date": "2016-11-10",
    "subject-areas": [
        {
            "$": "Immunology",
            "@code": "2403"
        },
        {
            "$": "Biochemistry",
            "@code": "1303"
        },
        {
            "$": "Hematology",
            "@code": "2720"
        },
        {
            "$": "Cell Biology",
            "@code": "1307"
        }
    ],
    "keywords": [],
    "authors": [
        "Shernan G. Holtan"
    ],
    "citedby-count": 39,
    "ref-count": 32,
    "ref-list": [
        "National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report",
        "Incidence and Outcome of Chronic Graft-versus-Host Disease Using National Institutes of Health Consensus Criteria",
        "Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD",
        "Risk and prognostic factors for acute GVHD based on NIH consensus criteria",
        "Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset",
        "National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen",
        "Feasibility of NIH consensus criteria for chronic graft-versus-host disease",
        "Acute graft-versus-host disease: A bench-to-bedside update",
        "Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802",
        "Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice",
        "The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair",
        "Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation",
        "Consensus conference on acute GVHD grading",
        "Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease",
        "Estimation of failure probabilities in the presence of competing risks: New representations of old estimators",
        "Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study",
        "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report",
        "New classification of chronic GVHD: Added clarity from the consensus diagnoses",
        "The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation",
        "The global severity of chronic graft-versus-host disease, determined by national institutes of health consensus criteria, is associated with overall survival and non-relapse mortality",
        "NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia",
        "Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease",
        "Failure-free survival after initial systemic treatment of chronic graft-versus-host disease",
        "Economics of hematopoietic cell transplantation",
        "Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens",
        "Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy",
        "Costs of allogeneic hematopoietic stem cell transplantation",
        "Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation",
        "Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair",
        "A Distinct Function of Regulatory T Cells in Tissue Protection",
        "Anti-inflammatory effects of epidermal growth factor on the immature human intestine",
        "Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Seattle",
            "affilname": "Fred Hutchinson Cancer Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Regensburg",
            "affilname": "Universit\u00e4t Regensburg",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Minneapolis",
            "affilname": "University of Minnesota Twin Cities",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Scottsdale",
            "affilname": "Mayo Clinic Scottsdale-Phoenix, Arizona",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Ann Arbor",
            "affilname": "University of Michigan, Ann Arbor",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Philadelphia",
            "affilname": "Penn Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "St. Louis",
            "affilname": "Washington University School of Medicine in St. Louis",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Buffalo",
            "affilname": "Roswell Park Cancer Institute",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cleveland",
            "affilname": "Cleveland Clinic Foundation",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Weill Cornell Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tokyo",
            "affilname": "National Cancer Center Hospital",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Portland",
            "affilname": "Oregon Health &amp; Science University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Stanford",
            "affilname": "Stanford Healthcare",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nashville",
            "affilname": "Vanderbilt University School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hamburg",
            "affilname": "Universit\u00e4tsklinikum Hamburg-Eppendorf",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Tampa",
            "affilname": "Moffitt Cancer Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Columbus",
            "affilname": "The Ohio State University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chapel Hill",
            "affilname": "UNC Health",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Harvard Medical School",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Rare Diseases Clinical Research Network",
        "National Institutes of Health",
        "National Cancer Institute",
        "National Cancer Institute",
        "National Center for Advancing Translational Sciences"
    ]
}